EE200200717A - Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid - Google Patents

Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid

Info

Publication number
EE200200717A
EE200200717A EEP200200717A EEP200200717A EE200200717A EE 200200717 A EE200200717 A EE 200200717A EE P200200717 A EEP200200717 A EE P200200717A EE P200200717 A EEP200200717 A EE P200200717A EE 200200717 A EE200200717 A EE 200200717A
Authority
EE
Estonia
Prior art keywords
depression
treatment
medicinal product
piperazine derivatives
anxiety neurosis
Prior art date
Application number
EEP200200717A
Other languages
English (en)
Inventor
Nakazato Atsuro
Chaki Shigeyuki
Okubo Taketoshi
Ogawa Shin-Ichi
Ishii Takaaki
Original Assignee
Taisho Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co., Ltd. filed Critical Taisho Pharmaceutical Co., Ltd.
Publication of EE200200717A publication Critical patent/EE200200717A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200200717A 2000-06-27 2001-06-27 Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid EE200200717A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000192856 2000-06-27
PCT/JP2001/005524 WO2002000259A1 (en) 2000-06-27 2001-06-27 Remedial agent for anxiety neurosis or depression and piperazine derivative

Publications (1)

Publication Number Publication Date
EE200200717A true EE200200717A (et) 2004-08-16

Family

ID=18691931

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200717A EE200200717A (et) 2000-06-27 2001-06-27 Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid

Country Status (22)

Country Link
US (1) US6949552B2 (et)
EP (1) EP1295608A4 (et)
JP (1) JP5002881B2 (et)
KR (1) KR20030013470A (et)
CN (1) CN1438897A (et)
AU (2) AU6634201A (et)
BG (1) BG107371A (et)
BR (1) BR0111976A (et)
CA (1) CA2413506A1 (et)
CZ (1) CZ20024165A3 (et)
EA (2) EA200500087A1 (et)
EE (1) EE200200717A (et)
HR (1) HRP20030056A2 (et)
HU (1) HUP0301719A2 (et)
IL (1) IL153706A0 (et)
MX (1) MXPA02012707A (et)
NO (1) NO20026122L (et)
NZ (1) NZ523800A (et)
PL (1) PL360286A1 (et)
SK (1) SK18322002A3 (et)
WO (1) WO2002000259A1 (et)
ZA (1) ZA200210386B (et)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0111976A (pt) 2000-06-27 2003-12-09 Taisho Pharmaceutical Co Ltd Preparação terapêutica para neurose ou depressão por ansiedade, e, derivado de piperazina
WO2003013571A1 (en) 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7354923B2 (en) 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US7655658B2 (en) 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7456184B2 (en) 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
US7732451B2 (en) 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
KR20040083472A (ko) * 2001-12-21 2004-10-02 다이쇼 세이야꾸 가부시끼가이샤 피페라진 유도체
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7968548B2 (en) * 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7419980B2 (en) * 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
CA2602267A1 (en) * 2005-04-04 2006-10-12 Takeda Pharmaceutical Company Limited Use of ramelteon to treat and prevent depression and anxiety disorders
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
WO2008039863A2 (en) * 2006-09-27 2008-04-03 Braincells, Inc. Composition comprising a melanocortin receptor (mcr) modulating agent alone or in combination with a second neurogenic agent for treating nervous system disorders
EP2072050A1 (en) * 2007-12-21 2009-06-24 Santhera Pharmaceuticals (Schweiz) AG Compounds with anti-emetic effect
BR112012005119A2 (pt) * 2009-09-07 2016-11-22 Vifor Int Ag novos antagonistas de hepcidina etanodiaminas
WO2012027495A1 (en) 2010-08-27 2012-03-01 University Of The Pacific Piperazinylpyrimidine analogues as protein kinase inhibitors
WO2012100342A1 (en) 2011-01-27 2012-08-02 Université de Montréal Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1317053A (fr) * 1961-03-17 1963-02-01 Soc Ind Fab Antibiotiques Sifa Nouveaux dérivés de la pipérazine, et procédé de préparation
CA918659A (en) * 1969-07-31 1973-01-09 Yoshitomi Pharmaceutical Industries 11-(4-substituted-1-piperazinyl)-dibenzo (b,f) (1,4) thiazepines
FR2601364B1 (fr) * 1986-07-09 1988-10-21 Adir Nouveaux derives de la piperazine dione-2,6, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
GB9021453D0 (en) 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
JPH0641071A (ja) * 1991-09-06 1994-02-15 Taisho Pharmaceut Co Ltd インドール酢酸エステル誘導体
GB9200293D0 (en) 1992-01-08 1992-02-26 Wyeth John & Brother Ltd Piperazine derivatives
SE9700620D0 (sv) * 1997-02-21 1997-02-21 Wapharm Ab Cykliska peptider med selektivitet för MSH-receptor subtyper
AU742425B2 (en) 1998-06-11 2002-01-03 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
BR0111976A (pt) 2000-06-27 2003-12-09 Taisho Pharmaceutical Co Ltd Preparação terapêutica para neurose ou depressão por ansiedade, e, derivado de piperazina

Also Published As

Publication number Publication date
CA2413506A1 (en) 2002-12-20
SK18322002A3 (sk) 2003-09-11
NO20026122D0 (no) 2002-12-19
US6949552B2 (en) 2005-09-27
IL153706A0 (en) 2003-07-06
NO20026122L (no) 2003-02-25
HRP20030056A2 (en) 2005-02-28
EP1295608A4 (en) 2004-03-31
AU2001266342B2 (en) 2005-01-27
AU6634201A (en) 2002-01-08
EA200300071A1 (ru) 2003-06-26
BG107371A (bg) 2003-08-29
EA005737B1 (ru) 2005-06-30
WO2002000259A1 (en) 2002-01-03
NZ523800A (en) 2005-02-25
CN1438897A (zh) 2003-08-27
BR0111976A (pt) 2003-12-09
HUP0301719A2 (hu) 2003-09-29
CZ20024165A3 (cs) 2004-03-17
JP5002881B2 (ja) 2012-08-15
EP1295608A1 (en) 2003-03-26
MXPA02012707A (es) 2003-04-25
KR20030013470A (ko) 2003-02-14
US20030186992A1 (en) 2003-10-02
EA200500087A1 (ru) 2005-06-30
ZA200210386B (en) 2004-02-10
PL360286A1 (en) 2004-09-06

Similar Documents

Publication Publication Date Title
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
EE200200442A (et) Piperasiini ja piperidiini derivaadid neuronaalsete kahjustuste raviks
LTC1345910I2 (lt) Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas
PL364865A1 (pl) Zastosowanie inhibitorów monoaminoksydazy do wytwarzania leków przeznaczonych do leczenia otyłości
DE60121992D1 (de) Zusammensetzung zur verabreichung und beschichtung medizinischer geräte
ATE318590T1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
ATE344253T1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60115418D1 (de) Mikroinfusionsvorrichtung zur verabreichung von medikamenten
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
IL153706A0 (en) Therapeutic preparation of anxiety neurosis or depression, and piperazine derivatives
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
EE200300167A (et) Amidoalküülpiperidiini ja -piperasiini derivaadid, neid sisaldav farmatseutiline kompositsioon ningühendite kasutamine närvisüsteemi häirete raviks
EE200200271A (et) Ravimkombinatsioonid ning nende kasutamine
EP1299337A4 (en) HYDROXYPHENSTATIN AND ITS PROMEDICATIONS
NO20023448D0 (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
ATE431142T1 (de) Arzneimittel zur behandlung und vermeidung neurogener schmerzen
PL367676A1 (en) Novel heterocyclic derivatives and medicinal use thereof
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
ATE359285T1 (de) Verwendung von scopinester derivaten zur herstellung von arzneimitteln
DE69937692D1 (de) Arzneimittel zur behandlung der hemicrania
DE60139306D1 (de) N-deacetylthiocolchin-derivate und diese enthaltende arzneimittel
EE04941B1 (et) Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine